Study of immune deficiency patients treated with subcutaneous immunoglobulin (IgPro20, Hizentra®) on weekly and biweekly schedules

Trial Identifier:	IgPro20_4005
Sponsor:	CSL Behring
Start Date:	March 2016
Primary Completion Date:	January 2018
Condition:	Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Canada	Montreal, Canada, QC H2W 1T7
Canada	Montreal, Canada, QC H3T 1C4

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.